KYMR

Companies
NASDAQ
Kymera Therapeutics Inc.
Health Care
Price Chart
Overview

About KYMR

kymera therapeutics is pioneering a transformative new approach to treating previously untreatable diseases. we are advancing the field of targeted protein degradation, accessing the body’s innate protein recycling machinery to degrade rather than inhibit dysregulated, disease-causing proteins. powered by a proprietary predictive modeling capability and a game-changing integrated degradation platform with a novel small molecule modality, our company is committed to accelerating drug discovery with an unmatched ability to target and degrade the most intractable of proteins, and advance new treatment options for patients. learn more at kymeratx.com.

Market Cap
$2.0B
Volume
30.9M
Avg. Volume
34.2M
P/E Ratio
-6.990354
Dividend Yield
0.00%
Employees
183.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.93
Moderate Correlation
Volatility
High (0.63)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for KYMR.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, KYMR shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$2.0B
Volume30.9M
P/E Ratio-6.99
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 27, 2025

PortfolioPilot Analysis

Get AI-powered insights on how KYMR fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025